{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:51:12Z","timestamp":1792727472147,"version":"4.5.0"},"reference-count":45,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.3201\/eid2806.212223","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T15:00:50Z","timestamp":1652886050000},"source":"Crossref","is-referenced-by-count":26,"title":["Effect of Recombinant Vesicular Stomatitis Virus\u2013Zaire Ebola Virus Vaccination on Ebola Virus Disease Illness and Death, Democratic Republic of the Congo"],"prefix":"10.3201","volume":"28","author":[{"given":"Neil","family":"Rupani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mbong Eta","family":"Ngole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Austin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam R.","family":"Aluisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Gainey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiromi M.","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina Kashibura","family":"Ntamwinja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruffin Mbusa","family":"Matafali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rigo Fraterne","family":"Muhayangabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiston Nganga","family":"Makoyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razia","family":"Laghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam C.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis S.","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2806.212223-202205091159-R1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev-pathol-052016-100506","article-title":"The pathogenesis of Ebola virus disease.","volume":"12","author":"Baseler","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"key-10.3201\/eid2806.212223-202205091159-R2","unstructured":"World Health Organization. Ebola virus disease. February 23, 2021 [cited 2021 Sep 26]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ebola-virus-disease"},{"key":"key-10.3201\/eid2806.212223-202205091159-R3","unstructured":"Centers for Disease Control and Prevention. Transmission: Ebola hemorrhagic fever. January 14, 2021 [cited 2021 Sep 26]. https:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/index.html"},{"key":"key-10.3201\/eid2806.212223-202205091159-R4","first-page":"891","article-title":"Assessment of ebola virus disease, health care infrastructure, and preparedness - four counties,Southeastern Liberia, august 2014.","volume":"63","author":"Forrester","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2806.212223-202205091159-R5","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1080\/21645515.2018.1473698","article-title":"The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials.","volume":"14","author":"Suder","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.3201\/eid2806.212223-202205091159-R6","unstructured":"Merck & Co. ERVEBO\u00ae (Ebola Zaire vaccine, live). United States Patent 8,012,489B2. 2019. [cited 2022 Apr 1]. https:\/\/www.merck.com"},{"key":"key-10.3201\/eid2806.212223-202205091159-R7","unstructured":"Ervebo (Ebola Zaire vaccine, live suspension for intramuscular injection): uses, dosage, side effects, interactions, warning. RxList. 2021 May 25 [cited 2021 Sep 26]. https:\/\/www.rxlist.com\/ervebo-drug.htm"},{"key":"key-10.3201\/eid2806.212223-202205091159-R8","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1586\/14737159.2015.1077117","article-title":"United States FDA\u2019s emergency use authorization of Ebola virus diagnostics: current impact and lessons for the future.","volume":"15","author":"Whitehouse","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"key-10.3201\/eid2806.212223-202205091159-R9","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.15585\/mmwr.mm6850a3","article-title":"CDC Ebola response. Ebola virus disease outbreak\u2014Democratic Republic of the Congo, August 2018\u2012-November 2019.","volume":"68","author":"Aruna","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2806.212223-202205091159-R10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1056\/NEJMoa1414216","article-title":"rVSV\u0394G-ZEBOV-GP Study Group. A recombinant vesicular stomatitis virus Ebola vaccine.","volume":"376","author":"Regules","year":"2017","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2806.212223-202205091159-R11","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1056\/NEJMoa1502924","article-title":"Phase 1 trials of rVSV Ebola vaccine in Africa and Europe.","volume":"374","author":"Agnandji","year":"2016","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2806.212223-202205091159-R12","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/S1473-3099(15)00154-1","article-title":"The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1\/2 trial.","volume":"15","author":"Huttner","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2806.212223-202205091159-R13","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/infdis\/jiy698","article-title":"PREVAIL I Cluster Vaccination Study with rVSV\u0394G-ZEBOV-GP as part of a public health response in Liberia.","volume":"219","author":"Bolay","year":"2019","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2806.212223-202205091159-R14","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1056\/NEJMoa1614067","article-title":"PREVAIL I Study Group. Phase 2 placebo-controlled trial of two vaccines to prevent Ebola in Liberia.","volume":"377","author":"Kennedy","year":"2017","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2806.212223-202205091159-R15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!).","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"key-10.3201\/eid2806.212223-202205091159-R16","doi-asserted-by":"publisher","first-page":"100038","DOI":"10.1016\/j.infpip.2020.100038","article-title":"The 2018\/19 Ebola epidemic the Democratic Republic of the Congo (DRC): epidemiology, outbreak control, and conflict.","volume":"2","author":"Shears","year":"2020","journal-title":"Infect Prev Pract"},{"key":"key-10.3201\/eid2806.212223-202205091159-R17","unstructured":"World Health Organization. Ebola virus disease vaccines [cited 2021 Sep 26]. https:\/\/www.who.int\/teams\/regulation-prequalification\/eul\/ebola-vaccines"},{"key":"key-10.3201\/eid2806.212223-202205091159-R18","unstructured":"US Food and Drug Administration. First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response. December 19, 2019 [cited 2021 Sep 26]. https:\/\/www.fda.gov\/news-events\/press-announcements\/first-fda-approved-vaccine-prevention-ebola-virus-disease-marking-critical-milestone-public-health"},{"key":"key-10.3201\/eid2806.212223-202205091159-R19","unstructured":"World Health Organization. Frequently asked questions: compassionate use of Ebola vaccine in the context of the Ebola outbreak in North Kivu, Democratic Republic of Congo [cited 2021 Sep 26]. https:\/\/www.afro.who.int\/publications\/frequently-asked-questions-compassionate-use-ebola-vaccine-context-ebola-outbreak"},{"key":"key-10.3201\/eid2806.212223-202205091159-R20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2471\/BLT.07.040089","article-title":"Vaccination greatly reduces disease, disability, death and inequity worldwide.","volume":"86","author":"Andre","year":"2008","journal-title":"Bull World Health Organ"},{"key":"key-10.3201\/eid2806.212223-202205091159-R21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jama.1996.03530250041024","article-title":"Efficacy of acellular pertussis vaccine in early childhood after household exposure.","volume":"275","author":"Schmitt","year":"1996","journal-title":"JAMA"},{"key":"key-10.3201\/eid2806.212223-202205091159-R22","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJMoa2107058","article-title":"Prevention and attenuation of COVID-19 with the BNT162b2 and mRNA-1273 vaccines.","volume":"385","author":"Thompson","year":"2021","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2806.212223-202205091159-R23","unstructured":"Xpert\u00ae Ebola Assay: instructions for use. Solna (Sweden): Cepheid; 2015 [cited 2021 Sep 26]. https:\/\/www.fda.gov\/media\/91944\/download"},{"key":"key-10.3201\/eid2806.212223-202205091159-R24","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S1473-3099(19)30118-5","article-title":"Medical countermeasures during the 2018 Ebola virus disease outbreak in the North Kivu and Ituri Provinces of the Democratic Republic of the Congo: a rapid genomic assessment.","volume":"19","author":"Mbala-Kingebeni","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2806.212223-202205091159-R25","unstructured":"World Health Organization. Clinical management of patients with viral haemorrhagic fever: a pocket guide for the front-line health worker. 2014 [cited 2021 Oct 8]. http:\/\/apps.who.int\/iris\/bitstream\/10665\/130883\/2\/WHO_HSE_PED_AIP_14.05.pdf"},{"key":"key-10.3201\/eid2806.212223-202205091159-R26","unstructured":"M\u00e9decins Sans Fronti\u00e8res. Filovirus haemorrhagic fever guideline. 2008 [cited 2021 Oct 8]. https:\/\/www.ghdonline.org\/uploads\/MSF_Ebola_2008.pdf"},{"key":"key-10.3201\/eid2806.212223-202205091159-R27","doi-asserted-by":"publisher","first-page":"394","DOI":"10.9745\/GHSP-D-16-00186","article-title":"Successful implementation of a multicountry clinical surveillance and data collection system for Ebola virus disease in West Africa: findings and lessons learned.","volume":"4","author":"Roshania","year":"2016","journal-title":"Glob Health Sci Pract"},{"key":"key-10.3201\/eid2806.212223-202205091159-R28","unstructured":"International Medical Corps. Viral hemorrhagic fever draft guidelines: standard clinical\/psychosocial procedures for Ebola treatment unit (ETU) operations [cited 2022 Apr 1]. https:\/\/internationalmedicalcorps.org"},{"key":"key-10.3201\/eid2806.212223-202205091159-R29","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"PALM Consortium Study Team. A randomized, controlled trial of Ebola virus disease therapeutics.","volume":"381","author":"Mulangu","year":"2019","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2806.212223-202205091159-R30","unstructured":"R Studio Team. RStudio: integrated development environment for R. Boston: RStudio, PBC; 2019 [cited 2021 Sep 26]. https:\/\/www.rstudio.com"},{"key":"key-10.3201\/eid2806.212223-202205091159-R31","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/aje\/kwp173","article-title":"Influenza vaccination and mortality: differentiating vaccine effects from bias.","volume":"170","author":"Fireman","year":"2009","journal-title":"Am J Epidemiol"},{"key":"key-10.3201\/eid2806.212223-202205091159-R32","doi-asserted-by":"publisher","first-page":"e0005700","DOI":"10.1371\/journal.pntd.0005700","article-title":"The natural history of acute Ebola Virus Disease among patients managed in five Ebola treatment units in West Africa: A retrospective cohort study.","volume":"11","author":"Skrable","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.3201\/eid2806.212223-202205091159-R33","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1056\/NEJMc1415318","article-title":"Ebola virus disease among children in West Africa.","volume":"372","author":"Agua-Agum","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2806.212223-202205091159-R34","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1056\/NEJMc1510305","article-title":"Ebola virus disease among male and female persons in West Africa.","volume":"374","author":"Agua-Agum","year":"2016","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2806.212223-202205091159-R35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s41256-021-00188-1","article-title":"Willingness of Greek general population to get a COVID-19 vaccine.","volume":"6","author":"Kourlaba","year":"2021","journal-title":"Glob Health Res Policy"},{"key":"key-10.3201\/eid2806.212223-202205091159-R36","doi-asserted-by":"publisher","first-page":"e0257096","DOI":"10.1371\/journal.pone.0257096","article-title":"Knowledge, beliefs, attitudes and perceived risk about COVID-19 vaccine and determinants of COVID-19 vaccine acceptance in Bangladesh.","volume":"16","author":"Mahmud","year":"2021","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2806.212223-202205091159-R37","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1016\/j.vaccine.2020.02.044","article-title":"Prior vaccination with recombinant Vesicular Stomatitis Virus - Zaire Ebolavirus vaccine is associated with improved survival among patients with Ebolavirus infection.","volume":"38","author":"Kasereka","year":"2020","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2806.212223-202205091159-R38","first-page":"h3740","article-title":"The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola.","volume":"351","author":"Ebola \u00e7a Suffit Ring Vaccination Trial Consortium","year":"2015","journal-title":"BMJ"},{"key":"key-10.3201\/eid2806.212223-202205091159-R39","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1126\/science.aab3920","article-title":"EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014\/15 Ebola virus outbreak strain.","volume":"349","author":"Marzi","year":"2015","journal-title":"Science"},{"key":"key-10.3201\/eid2806.212223-202205091159-R40","doi-asserted-by":"publisher","first-page":"S360","DOI":"10.1093\/infdis\/jiw218","article-title":"Efficacy of vesicular stomatitis virus\u2012Ebola virus postexposure treatment in rhesus macaques infected with Ebola virus Makona.","volume":"214","author":"Marzi","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2806.212223-202205091159-R41","doi-asserted-by":"publisher","first-page":"S785","DOI":"10.1093\/infdis\/jir298","article-title":"Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany.","volume":"204","author":"G\u00fcnther","year":"2011","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2806.212223-202205091159-R42","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/cid\/ciw256","article-title":"Use of postexposure prophylaxis after occupational exposure to Zaire ebolavirus.","volume":"63","author":"Wong","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2806.212223-202205091159-R43","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1093\/cid\/civ131","article-title":"Risk of misinterpretation of Ebola virus PCR results after rVSV ZEBOV-GP vaccination.","volume":"60","author":"Cnops","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2806.212223-202205091159-R44","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1001\/jama.2015.1995","article-title":"Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick.","volume":"313","author":"Lai","year":"2015","journal-title":"JAMA"},{"key":"key-10.3201\/eid2806.212223-202205091159-R45","doi-asserted-by":"publisher","first-page":"721328","DOI":"10.3389\/fimmu.2021.721328","article-title":"Review: insights on current FDA-approved monoclonal antibodies against Ebola virus infection.","volume":"12","author":"Tshiani Mbaya","year":"2021","journal-title":"Front Immunol"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/28\/6\/21-2223_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:55:55Z","timestamp":1732989355000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/28\/6\/21-2223_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2806.212223","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}